Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.

Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.

Item
http://www.wikidata.org/entity/Q36013094
Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis.Noncompliance in the use of cardiovascular medications in the Medicare Part D populationChronic stable angina is associated with lower health-related quality of life: evidence from Chinese patients.Cardiovascular medication: improving adherence.Do we prescribe what patients prefer? Pilot study to assess patient preferences for medication regimen characteristics.Drug holidays: the most frequent type of noncompliance with calcium plus vitamin D supplementation in persistent patients with osteoporosis.Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysisEvidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications.Beta-Blockers and Calcium Channel Blockers: First Line Agents.Tacrolimus prolonged release in kidney transplantation.Opportunities to reduce medication regimen complexity: a retrospective analysis of patients discharged from a university hospital in Germany.Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris.
P2860

Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.

Item
http://www.wikidata.org/entity/Q36013094
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Compliance, clinical outcome, ...... a randomized controlled trial.
@ast
Compliance, clinical outcome, ...... a randomized controlled trial.
@en
type
label
Compliance, clinical outcome, ...... a randomized controlled trial.
@ast
Compliance, clinical outcome, ...... a randomized controlled trial.
@en
prefLabel
Compliance, clinical outcome, ...... a randomized controlled trial.
@ast
Compliance, clinical outcome, ...... a randomized controlled trial.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Compliance, clinical outcome, ...... a randomized controlled trial.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932